Glycosmedia

Diabetes News Service

  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

Diabetes News June 25th 2010

June 25th 2010

Mixtard 30 withdrawal – alternative insulins
Novo Nordisk is withdrawing Mixtard 30 from the market by 31 December 2010 … This information is taken from the Diabetes Update insulin chart, Spring 2010 (Diabetes UK)

Insulin initiation in primary care for patients with type 2 diabetes: 3-Year follow-up study
Findings suggest scope for further intensification of insulin therapy in order to improve on the glycaemic control achieved during the first 6 months post-insulin initiation (Primary Care Diabetes)

Continuous Subcutaneous Insulin Infusion
Clinical evidence to help you understand more about insulin pump therapy (Technology Adoption Centre, NHS)

Diabetes Patient Experience Project
The NHS Information Centre for Health & Social Care initiated the Diabetes Patient Experience Project with the aim of capturing the service experiences of users with diabetes in order to support the Diabetes National Service Framework (Picker Institute Europe)

Management of microvascular complications of type 2 diabetes mellitus
This guideline synthesis compares the recommendations from three guidelines: American Association of Clinical Endocrinologists – National Collaborating Center for Chronic Conditions/National Institute for Health and Clinical Excellence – University of Michigan Health System (National Guidelines Clearinghouse)

Primary Care Diabetes
Volume 4, Issue 2, Pages 67-126 (July 2010) (Primary Care Diabetes)

Diabeteic hypoglycaemia a new online journal
(Hypodiab.com)

Artificial Pancreas Gets Real
New system regulates blood glucose levels (Boston University)

NIH Study Finds That Overweight Girls Who Lose Weight Reduce Adult Diabetes Risk
Overweight girls who lose weight before they reach adulthood greatly reduced their risk for developing type 2 diabetes, according to researchers from the National Institutes of Health and Harvard University, who analyzed 16 years of data on nearly 110,000 women (NIH)

Diabetes care management program lowered health care costs, hospitalizations
A telephone-based diabetes disease management program was associated with significant reductions in health care costs and rates of hospitalization for Medicare patients with diabetes and cardiovascular disease (Endocrine Today)

New Role for Ancient Clock
The pancreas has its own molecular clock. Now, for the first time, a Northwestern University study has shown this ancient circadian clock regulates the production of insulin. If the clock is faulty, the result is diabetes (Northwestern University, USA)

Australia’s health 2010 is the 12th biennial health report
Section 4.3 Diabetes (AIHW)

Dapagliflozin treatment in patients with different stages of type 2 diabetes mellitus
Abstract – Dapagliflozin treatment at 10 and 20 mg QD for 12 weeks resulted in significant improvement in glycaemic control and body weight reduction in both early-stage and late-stage patients with T2DM (Diabetes, Obesity and Metabolism)

Diamyd Medical Signs Agreement for Diabetes Therapy
The agreement relates to the development and world-wide commercialization of the GAD65 antigen-based therapy (Diamyd®) for the treatment and prevention of type 1 diabetes and associated conditions (Diamyd)

Facebook Game Helps People with Diabetes Improve Everyday Behaviors
While the benefits of the game are available to anyone, HealthSeeker specifically helps people with diabetes make more informed lifestyle decisions in an innovative way that complements their daily use of social media (Joslin Diabetes Center)

Categories: News Pre-2012

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Platinum Sponsor

Sanofi Diabetes

Gold Sponsors

Novo NordiskAstraZenecaNapp DiabetesBoehringer Ingelheim LillyMSD

Silver Sponsors

Welsh Endocrinology and Diabetes Society (WEDS)Abbott Diabetes Care

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

Join us on Facebook

Join us on Facebook

Share Glycosmedia

Follow us on Twitter

My Tweets

Glycosmedia App

mobileA Glycosmedia iPhone/iPad App is available FREE from the iTunes store.


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com


HONcode Standard

HONConduct783211_s2This site complies with the HONcode standard for trustworthy health information: verify here.

Copyright © 2018 Glycosmedia Partnership